Caffeine as a metabolic probe: a comparison of the metabolic ratios used to assess CYP1A2 activity.
- 1 January 1995
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 39 (1) , 65-69
- https://doi.org/10.1111/j.1365-2125.1995.tb04411.x
Abstract
1. Caffeine is widely used as an in vivo probe for CYP1A2; the distribution/activity of this enzyme is reported to be reflected by metabolic ratios. 2. Several metabolic ratios using different combinations of urinary metabolites have been used to measure CYP1A2, with varying conclusions on its distribution. 3. A mathematical comparison of five metabolic ratios claiming to reflect CYP1A2 activity was made using data from 237 healthy volunteers. 4. All five metabolic ratios were symmetrically distributed. The five ratios however, measured at least three different parameters, with no one ratio correlating exactly with any other. 5. Data in the literature claiming to measure CYP1A2 using caffeine may reflect other parameters. 6. The complex metabolism of caffeine together with different parameters controlling the renal clearance of each metabolite, makes the use of urinary metabolic ratios an inaccurate probe for assessing the distribution of CYP1A2 activity in populations.Keywords
This publication has 20 references indexed in Scilit:
- Caffeine as a probe for CYP1A2 activityPharmacogenetics, 1994
- Rapid method for the routine determination of caffeine and its metabolites by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1994
- Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolitesPharmacogenetics, 1992
- Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1Pharmacogenetics, 1992
- Foreign compound metabolism capacity in man measured from metabolites of dietary caffeineCarcinogenesis: Integrative Cancer Research, 1992
- Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines.Proceedings of the National Academy of Sciences, 1989
- Quantitative assessment of caffeine partial clearances in man.British Journal of Clinical Pharmacology, 1986
- Effect of allopurinol on caffeine disposition in man.British Journal of Clinical Pharmacology, 1986
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977
- Genetic Control of Isoniazid Metabolism in ManBMJ, 1960